Astellas bought Xyphos in 2019 in a $500 million-plus deal that included an upfront payment of $120 million, putting the ...

Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for ...

Zepbound brought in first-quarter sales of $517 million, ahead of analyst expectations, while Mounjaro added $1.8 billion, ...

The vaccine – developed by researchers at the University of Florida (UF) in the US – is based on mRNA taken from the ...

Jacobio Pharma has reported the results of its pivotal Chinese study of KRAS G12C inhibitor glecirasib, with a safety profile ...

The FDA notes that the Apple Atrial Fibrillation History Feature – which provides a non-invasive way to check estimates of AFib burden – has now been qualified as a biomarker test that can be used as ...

Boehringer Ingelheim, GSK, Novartis, Teva, and Covis Pharma have been taken to task for asthma and COPD inhalers, while ...

It’s really important that we create pathways for people to enter the life sciences industry from all backgrounds and no ...

Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate ...

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached on a ...

Hospital staff in the UK have developed and piloted an app that can help patients monitor their progress to recovery after ...

WASHINGTON, D.C., April 30, 2024 –The Food and Drug Administration’s (FDA) final rule has reclassified laboratory developed ...